share_log

What the Options Market Tells Us About Bristol-Myers Squibb

What the Options Market Tells Us About Bristol-Myers Squibb

期權市場告訴我們施貴寶的情況
Benzinga ·  16:01

Deep-pocketed investors have adopted a bearish approach towards Bristol-Myers Squibb (NYSE:BMY), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in BMY usually suggests something big is about to happen.

財力雄厚的投資者對百時美施貴寶(紐約證券交易所代碼:BMY)採取了看跌態度,這是市場參與者不容忽視的。我們對本辛加公開期權記錄的追蹤今天揭示了這一重大舉措。這些投資者的身份仍然未知,但是BMY的如此大幅的變動通常表明即將發生重大事件。

We gleaned this information from our observations today when Benzinga's options scanner highlighted 28 extraordinary options activities for Bristol-Myers Squibb. This level of activity is out of the ordinary.

我們今天從觀察中收集了這些信息,當時Benzinga的期權掃描儀重點介紹了百時美施貴寶的28項非凡期權活動。這種活動水平與衆不同。

The general mood among these heavyweight investors is divided, with 35% leaning bullish and 60% bearish. Among these notable options, 2 are puts, totaling $78,250, and 26 are calls, amounting to $2,153,022.

這些重量級投資者的總體情緒存在分歧,35%的人傾向於看漲,60%的人看跌。在這些值得注意的期權中,有兩個是看跌期權,總額爲78,250美元,26個是看漲期權,總額爲2,153,022美元。

Predicted Price Range

預測的價格區間

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $30.0 to $50.0 for Bristol-Myers Squibb during the past quarter.

分析這些合約的交易量和未平倉合約,看來大型企業一直在關注百時美施貴寶在過去一個季度的價格範圍從30.0美元到50.0美元不等。

Analyzing Volume & Open Interest

分析交易量和未平倉合約

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.

查看交易量和未平倉合約是一種對股票進行盡職調查的有見地的方法。

This data can help you track the liquidity and interest for Bristol-Myers Squibb's options for a given strike price.

這些數據可以幫助您跟蹤給定行使價下百時美施貴寶期權的流動性和利息。

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Bristol-Myers Squibb's whale activity within a strike price range from $30.0 to $50.0 in the last 30 days.

下面,我們可以分別觀察百時美施貴寶在過去30天行使價範圍內所有鯨魚活動的看漲和看跌期權交易量和未平倉合約的變化。

Bristol-Myers Squibb Option Activity Analysis: Last 30 Days

百時美施貴寶期權活動分析:過去 30 天

1721332876_0.png

Noteworthy Options Activity:

值得注意的期權活動:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
BMY CALL TRADE BULLISH 06/20/25 $7.15 $6.85 $7.1 $40.00 $852.0K 747 42
BMY CALL SWEEP BEARISH 08/16/24 $1.45 $1.42 $1.43 $44.00 $248.8K 2.8K 774
BMY CALL SWEEP BEARISH 08/02/24 $2.98 $2.9 $2.9 $41.00 $116.0K 515 34
BMY CALL SWEEP BULLISH 08/16/24 $1.42 $1.39 $1.42 $44.00 $108.2K 2.8K 12
BMY CALL TRADE BULLISH 07/26/24 $0.45 $0.42 $0.45 $46.00 $67.5K 510 207
符號 看跌/看漲 交易類型 情緒 Exp。日期 出價 價格 行使價 總交易價格 未平倉合約 音量
BMY 打電話 貿易 看漲 06/20/25 7.15 美元 6.85 美元 7.1 美元 40.00 美元 852.0 萬美元 747 42
BMY 打電話 粗魯的 08/16/24 1.45 美元 1.42 1.43 美元 44.00 美元 248.8 萬美元 2.8K 774
BMY 打電話 粗魯的 08/02/24 2.98 美元 2.9 美元 2.9 美元 41.00 美元 116.0 萬美元 515 34
BMY 打電話 看漲 08/16/24 1.42 1.39 美元 1.42 44.00 美元 108.2 萬美元 2.8K 12
BMY 打電話 貿易 看漲 07/26/24 0.45 美元 0.42 美元 0.45 美元 46.00 美元 67.5 萬美元 510 207

About Bristol-Myers Squibb

關於百時美施貴寶

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

百時美施貴寶發現、開發和銷售用於心血管、癌症和免疫疾病等各種治療領域的藥物。布里斯托爾的重點是免疫腫瘤學,該公司是該領域的藥物開發領導者。布里斯托爾將近70%的總銷售額來自美國,這表明其對美國市場的依賴程度高於大多數同行。

Having examined the options trading patterns of Bristol-Myers Squibb, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance

在研究了百時美施貴寶的期權交易模式之後,我們的注意力現在直接轉向了該公司。這種轉變使我們能夠深入研究其目前的市場地位和表現

Current Position of Bristol-Myers Squibb

百時美施貴寶的現狀

  • Currently trading with a volume of 14,236,612, the BMY's price is down by -1.58%, now at $42.47.
  • RSI readings suggest the stock is currently may be approaching overbought.
  • Anticipated earnings release is in 8 days.
  • BMY目前的交易量爲14,236,612美元,價格下跌了-1.58%,目前爲42.47美元。
  • RSI讀數表明,該股目前可能接近超買。
  • 預計業績將在8天后發佈。

What The Experts Say On Bristol-Myers Squibb

專家對百時美施貴寶的看法

In the last month, 1 experts released ratings on this stock with an average target price of $41.0.

上個月,1位專家發佈了該股的評級,平均目標價爲41.0美元。

  • Maintaining their stance, an analyst from Barclays continues to hold a Equal-Weight rating for Bristol-Myers Squibb, targeting a price of $41.
  • 巴克萊銀行的一位分析師堅持其立場,繼續對百時美施貴寶持有同等權重評級,目標價格爲41美元。

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Bristol-Myers Squibb options trades with real-time alerts from Benzinga Pro.

期權交易帶來更高的風險和潛在的回報。精明的交易者通過不斷自我教育、調整策略、監控多個指標以及密切關注市場走勢來管理這些風險。通過 Benzinga Pro 的實時提醒,隨時了解百時美施貴寶期權的最新交易。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論